E-LIB Suche - Ergebnisse für: Lacombe, Maud

1

Feasibility, safety, efficacy and potential scaling-up of s..:

Lacombe, Karine ; Moh, Raoul ; Chazallon, Corine...
Scientific Reports. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

2

Patient-reported outcomes with direct-acting antiviral trea..:

Marcellin, Fabienne ; Mourad, Abbas ; Lemoine, Maud...
JHEP Reports. 5 (2023) 3 - p. 100665 , 2023

Link: https://doi.org/10.1016/..

3

Farnesoid X receptor alpha ligands inhibit HDV in vitro rep..:

Legrand, Anne-Flore ; Lucifora, Julie ; Lacombe, Benoît...
Hepatology Communications. 7 (2023) 5 - p. , 2023

Link: https://doi.org/10.1097/..

4

A community-based strategy to eliminate hepatitis C among p..:

Nagot, Nicolas ; Binh, Nguyen Thanh ; Hong, Tran Thi...
The Lancet Regional Health - Western Pacific. 37 (2023) - p. 100801 , 2023

Link: https://doi.org/10.1016/..

5

A community-based strategy to eliminate hepatitis C among p..:

Nagot, Nicolas ; Binh, Nguyen Thanh ; Hong, Tran Thi...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.lanwpc.2023.100801. , 2023

Link: https://hal.science/hal-..

6

Farnesoid X receptor alpha ligands inhibit HDV in vitro rep..:

Legrand, Anne-Flore ; Lucifora, Julie ; Lacombe, Benoît...
info:eu-repo/semantics/altIdentifier/doi/10.1097/HC9.0000000000000078. , 2023

Link: https://hal.science/hal-..

7

Patient-reported outcomes with direct-acting antiviral trea..:

Fabienne Marcellin ; Abbas Mourad ; Maud Lemoine...
http://www.sciencedirect.com/science/article/pii/S2589555922002373. , 2023

Link: https://doi.org/10.1016/..

8

Farnesoid X receptor alpha ligands inhibit HDV in vitro rep..:

Legrand, Anne-Flore ; Lucifora, Julie ; Lacombe, Benoît...
info:eu-repo/semantics/altIdentifier/doi/10.1097/HC9.0000000000000078. , 2023

Link: https://hal.science/hal-..

9

A community-based strategy to eliminate hepatitis C among p..:

Nagot, Nicolas ; Binh, Nguyen Thanh ; Hong, Tran Thi...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.lanwpc.2023.100801. , 2023

Link: https://hal.science/hal-..

10

Farnesoid X receptor alpha ligands inhibit HDV in vitro rep..:

Legrand, Anne-Flore ; Lucifora, Julie ; Lacombe, Benoît...
info:eu-repo/semantics/altIdentifier/doi/10.1097/HC9.0000000000000078. , 2023

Link: https://hal.science/hal-..

11

Farnesoid X receptor alpha ligands inhibit HDV in vitro rep..:

Legrand, Anne-Flore ; Lucifora, Julie ; Lacombe, Benoît...
info:eu-repo/semantics/altIdentifier/doi/10.1097/HC9.0000000000000078. , 2023

Link: https://hal.science/hal-..

12

Farnesoid X receptor alpha ligands inhibit HDV in vitro rep..:

Legrand, Anne-Flore ; Lucifora, Julie ; Lacombe, Benoît...
info:eu-repo/semantics/altIdentifier/doi/10.1097/HC9.0000000000000078. , 2023

Link: https://hal.science/hal-..

13

A community-based strategy to eliminate hepatitis C among p..:

Nagot, Nicolas ; Binh, Nguyen Thanh ; Hong, Tran Thi...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.lanwpc.2023.100801. , 2023

Link: https://hal.science/hal-..

14

Cost-utility analysis of four WHO-recommended sofosbuvir-ba..:

Boyer, Sylvie ; Baudoin, Maël ; Nishimwe, Marie Libérée...
BMC Health Services Research. 22 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

15

Portal Glucose Infusion, Afferent Nerve Fibers, and Glucose..:

Joly-Amado, Aurélie ; Soty, Maud ; Philippe, Erwann...
The Journal of Nutrition. 152 (2022) 8 - p. 1862-1871 , 2022

Link: https://doi.org/10.1093/..